Patient-Tailored Aortic Valve Replacement

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Patient-Tailored Aortic Valve Replacement. / De Backer, Ole; Wong, Ivan; Wilkins, Ben; Carranza, Christian Lildal; Søndergaard, Lars.

I: Frontiers in Cardiovascular Medicine, Bind 8, 658016, 2021.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

De Backer, O, Wong, I, Wilkins, B, Carranza, CL & Søndergaard, L 2021, 'Patient-Tailored Aortic Valve Replacement', Frontiers in Cardiovascular Medicine, bind 8, 658016. https://doi.org/10.3389/fcvm.2021.658016

APA

De Backer, O., Wong, I., Wilkins, B., Carranza, C. L., & Søndergaard, L. (2021). Patient-Tailored Aortic Valve Replacement. Frontiers in Cardiovascular Medicine, 8, [658016]. https://doi.org/10.3389/fcvm.2021.658016

Vancouver

De Backer O, Wong I, Wilkins B, Carranza CL, Søndergaard L. Patient-Tailored Aortic Valve Replacement. Frontiers in Cardiovascular Medicine. 2021;8. 658016. https://doi.org/10.3389/fcvm.2021.658016

Author

De Backer, Ole ; Wong, Ivan ; Wilkins, Ben ; Carranza, Christian Lildal ; Søndergaard, Lars. / Patient-Tailored Aortic Valve Replacement. I: Frontiers in Cardiovascular Medicine. 2021 ; Bind 8.

Bibtex

@article{43f94e85b59f4d8e8f5c73d80a318895,
title = "Patient-Tailored Aortic Valve Replacement",
abstract = "Contemporary surgical and transcatheter aortic valve interventions offer effective therapy for a broad range of patients with severe symptomatic aortic valve disease. Both approaches have seen significant advances in recent years. Guidelines have previously emphasized 'surgical risk' in the decision between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR), although this delineation becomes increasingly obsolete with more evidence on the effectiveness of TAVR in low surgical risk candidates. More importantly, decisions in tailoring aortic valve interventions should be patient-centered, accounting not only for operative risk, but also anatomy, lifetime management and specific co-morbidities. Aspects to be considered in a patient-tailored aortic valve intervention are discussed in this article.",
keywords = "aortic valve disease, replacement, repair, surgery, transcatheter, BUNDLE-BRANCH BLOCK, ROOT REPLACEMENT, CORONARY ACCESS, TRANSCATHETER, IMPACT, REGURGITATION, STENOSIS, OUTCOMES, DISEASE",
author = "{De Backer}, Ole and Ivan Wong and Ben Wilkins and Carranza, {Christian Lildal} and Lars S{\o}ndergaard",
year = "2021",
doi = "10.3389/fcvm.2021.658016",
language = "English",
volume = "8",
journal = "Frontiers in Cardiovascular Medicine",
issn = "2297-055X",
publisher = "Frontiers Media",

}

RIS

TY - JOUR

T1 - Patient-Tailored Aortic Valve Replacement

AU - De Backer, Ole

AU - Wong, Ivan

AU - Wilkins, Ben

AU - Carranza, Christian Lildal

AU - Søndergaard, Lars

PY - 2021

Y1 - 2021

N2 - Contemporary surgical and transcatheter aortic valve interventions offer effective therapy for a broad range of patients with severe symptomatic aortic valve disease. Both approaches have seen significant advances in recent years. Guidelines have previously emphasized 'surgical risk' in the decision between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR), although this delineation becomes increasingly obsolete with more evidence on the effectiveness of TAVR in low surgical risk candidates. More importantly, decisions in tailoring aortic valve interventions should be patient-centered, accounting not only for operative risk, but also anatomy, lifetime management and specific co-morbidities. Aspects to be considered in a patient-tailored aortic valve intervention are discussed in this article.

AB - Contemporary surgical and transcatheter aortic valve interventions offer effective therapy for a broad range of patients with severe symptomatic aortic valve disease. Both approaches have seen significant advances in recent years. Guidelines have previously emphasized 'surgical risk' in the decision between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR), although this delineation becomes increasingly obsolete with more evidence on the effectiveness of TAVR in low surgical risk candidates. More importantly, decisions in tailoring aortic valve interventions should be patient-centered, accounting not only for operative risk, but also anatomy, lifetime management and specific co-morbidities. Aspects to be considered in a patient-tailored aortic valve intervention are discussed in this article.

KW - aortic valve disease

KW - replacement

KW - repair

KW - surgery

KW - transcatheter

KW - BUNDLE-BRANCH BLOCK

KW - ROOT REPLACEMENT

KW - CORONARY ACCESS

KW - TRANSCATHETER

KW - IMPACT

KW - REGURGITATION

KW - STENOSIS

KW - OUTCOMES

KW - DISEASE

U2 - 10.3389/fcvm.2021.658016

DO - 10.3389/fcvm.2021.658016

M3 - Review

C2 - 33969021

VL - 8

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

SN - 2297-055X

M1 - 658016

ER -

ID: 302153322